key: cord-0312607-70bhasjw authors: Maurya, D.; Kaur, A.; Faraz, F.; Tandon, S.; Rana, A.; Grover, S. title: Assessment of breakthrough infections among post-vaccinated healthcare workers in a Tertiary Dental Hospital in New Delhi, India date: 2021-11-16 journal: nan DOI: 10.1101/2021.11.15.21266333 sha: 2d0aa8dcc2bfa73985ffcb51381031f5da568134 doc_id: 312607 cord_uid: 70bhasjw Background: COVID-19 vaccination in India has been rolled out on a national level, with healthcare workers (HCWs) becoming the first recipient of both Covishield and Covaxin. However, concerns over efficacy of vaccines have been much debated. This study highlights COVID-19 infections among vaccinated HCWs in a teaching dental hospital in Delhi, India. Methodology: This cross-sectional survey was conducted using a pretested, validated, self-instituted questionnaire assessing COVID-19 like symptoms and/or confirmed infections among partially or fully vaccinated HCWs (all faculty, staff and students) of the institute from 16th January to 31st July 2021. The number of infections was also matched with hospital records. Results: Out of 397 HCWs, 386 (97.2%) were vaccinated and 355 (89.4%) had received both doses. COVID-19 like symptoms appeared in 21 HCWs (5.4%) post any dose of vaccine. Symptomatic breakthrough infections >14 days after second dose occurred was seen in 16 HCWs (4.5%). Except one (required hospitalization), all other cases had mild infection. No significant difference was observed between Covishield and Covaxin. Most common symptom was fever and body ache. Conclusion: The study identifies the possibility of breakthrough infections among vaccinated HCWs, and ensures the impact of vaccination in limiting disease severity. The findings suggest that COVID-19 preventive measures should be continued even among vaccinated individuals. Coronavirus disease or COVID-19, caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), has gained worldwide attention since its origin in December 2019, and subsequent progression to a pandemic in March 2020. India has been one of its hotspots, reporting over 34 million cases and 4.5 lakh deaths by mid-October 2021 1 . Several measures have been implemented to control and combat this disease. Evidence suggests that COVID-19 associated disease severity, hospitalization, and death rates can be substantially reduced by Vaccination, in both clinical trial 2 and real-world settings 3 Hence, this study was conducted to assess COVID-19 infections post-vaccination among HCWs in a tertiary dental care hospital in New Delhi, India 8 . The present study is a questionnaire-based, single-centre, cross-sectional survey assessing A summary of vaccination details and infection rates has been described in Table 1 (Figure 1 ). Table 3 presents details of various symptoms and outcome reported by infected HCWs. Fever (63%) and body ache (63%) were the most commonly reported symptoms. The prevalence . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Although health care workers (HCWs) from all specialties are at a high risk of exposure, the risk for dental professionals is theoretically more, owing to the proximity with the patients during oral examinations, substantiated by potential for direct exposure due to aerosol-generating procedures and use of high-vacuum suction 10 . Therefore, it becomes all the more pertinent to assess the real world effectiveness among this cadre of health care professionals. The present study showed incidence of breakthrough infections among HCWs to be 4.5% while 6.4% were having COVID-19 like symptoms. This is much lower than that reported from a similar study This difference could be probably due to increased awareness levels and coherence to adoption of COVID-19 appropriate behavior among HCWs in this institution. The most common symptom presentation were fever and body ache among the infected HCWs in the present study. Other symptoms included cough, loss of taste and smell. Similar . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 16, 2021. ; https://doi.org/10.1101/2021.11.15.21266333 doi: medRxiv preprint findings were reported in studies done elsewhere 11, 13 . For 2 HCWs, symptom persisted for more than 2 weeks. The findings are similar to study by Tyagi et al 11 . Among the 16 HCWs with breakthrough infections, six (37.5%) did not report any family member contracting the infection while 10 (62.5%) reported 2 or more family members getting infected with SARS CoV-2 in the present study. The updated systematic review and metaanalysis of 87 studies from 30 countries have reported secondary attack rate at household level to be 19% 15 . Higher rate in our study could be due to the fact that since our respondents were HCWs, they might have a higher viral load due to high risk of exposure, and hence the infectivity. The cross-sectional nature of the study, single center assessment and small sample size limits the credibility of the study. Also, clinically relevant variables such as comorbities, age, gender, etc were not explored due to logistic reasons. However, this study strongly helps in identify the impact of vaccinations in real-world settings. It is comforting that the prevalence of breakthrough infections was less prevalent and mostly mild in severity, indicating that if not infection; vaccines have at least shielded the severe reaction from the disease. However, this may also create a possibility that there could be asymptomatic carriers among exposed HCWs. Nevertheless, dental healthcare facilities being at the highest risk of infection are required to assess their HCWs for possible symptoms and spread of infection. Breakthrough infections thus should be focus of interest for healthcare institutions caring for COVID-19 patients and community dwelling individuals. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 16, 2021. ; https://doi.org/10.1101/2021.11.15.21266333 doi: medRxiv preprint Coronavirus cases Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19 BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting SARS-CoV-2 infection after COVID-19 immunization in healthcare workers: A retrospective, pilot study Concerns and motivations about COVID-19 vaccination Centre for Disease Control and Prevention (CDC) SARS-CoV-2 infection after vaccination in health care workers in California Maulana Azad Institute of Dental Sciences (An autonomous institute under Govt of NCT of Delhi). Official Website: www.maids.ac Centre for Disease Control and Prevention (CDC) Commentary: Oral Health and COVID-19: Increasing the Need for Prevention and Access Breakthrough COVID19 infections after vaccinations in healthcare and other workers in a chronic care medical facility Post-vaccination SARS-CoV-2 infections among skilled nursing facility residents and staff members Covid-19 Breakthrough Infections in Vaccinated Health Care Workers Antibody response after first and second-dose of ChAdOx1-nCOV (Covishield TM ®) and BBV-152 (Covaxin TM ®) among health care workers in India: The final results of cross-sectional coronavirus vaccine-induced antibody titre (COVAT) study Factors Associated With Household Transmission of SARS-CoV-2 An Updated Systematic Review and Meta